1. Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma
- Author
-
Kawakita, Daisuke, primary, Nagao, Toshitaka, additional, Takahashi, Hideaki, additional, Kano, Satoshi, additional, Honma, Yoshitaka, additional, Hirai, Hideaki, additional, Saigusa, Natsuki, additional, Akazawa, Kohei, additional, Tani, Kaori, additional, Ojiri, Hiroya, additional, Tsukahara, Kiyoaki, additional, Ozawa, Hiroyuki, additional, Okami, Kenji, additional, Kondo, Takahito, additional, Togashi, Takafumi, additional, Fushimi, Chihiro, additional, Shimura, Tomotaka, additional, Shimizu, Akira, additional, Okamoto, Isaku, additional, Okada, Takuro, additional, Imanishi, Yorihisa, additional, Watanabe, Yoshihiro, additional, Otsuka, Kuninori, additional, Sakai, Akihiro, additional, Ebisumoto, Koji, additional, Sato, Yuichiro, additional, Yamazaki, Keisuke, additional, Ueki, Yushi, additional, Hanazawa, Toyoyuki, additional, Saito, Yuki, additional, Ando, Mizuo, additional, Matsuki, Takashi, additional, Nakaguro, Masato, additional, Sato, Yukiko, additional, Urano, Makoto, additional, Utsumi, Yoshitaka, additional, Kohsaka, Shinji, additional, Saotome, Takashi, additional, and Tada, Yuichiro, additional
- Published
- 2022
- Full Text
- View/download PDF